Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference
February 01 2024 - 7:00AM
Business Wire
Revance Therapeutics, Inc. (RVNC), today announced that the
company will be participating in the Guggenheim Healthcare Talks,
6th Annual Biotechnology Conference, taking place February 7-8,
2024, in New York, New York. Chief Executive Officer, Mark J.
Foley, is scheduled to participate in a fireside chat on Thursday,
February 8, at 9:30a.m. EST.
Interested parties can access the live audio webcast for this
conference from the Investor Relations section of the company's
website at www.revance.com. The webcast replay will be available
after the conclusion of the live presentation for approximately 90
days.
About Revance
Revance is a biotechnology company setting the new standard in
healthcare with innovative aesthetic and therapeutic offerings that
enhance patient outcomes and physician experiences. Revance’s
portfolio includes DAXXIFY (daxibotulinumtoxinA-lanm) for injection
and the RHA Collection of dermal fillers in the U.S. Revance has
also partnered with Viatris Inc. to develop a biosimilar to
onabotulinumtoxinA for injection and Shanghai Fosun Pharmaceutical
to commercialize DAXXIFY in China.
Revance is headquartered in Nashville, Tenn., with additional
office locations in Newark and Irvine, Calif. Learn more at
www.Revance.com, www.RevanceAesthetics.com,
www.DAXXIFY.com, https://hcp.daxxifytherapy.com/, or
connect with us on LinkedIn.
“Revance”, the Revance logo, and DAXXIFY are registered
trademarks of Revance Therapeutics, Inc. Resilient Hyaluronic Acid®
and RHA are trademarks of TEOXANE SA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201633021/en/
Investors Revance Therapeutics, Inc.: Jessica Serra,
510-279-6886 jessica.serra@revance.com or Gilmartin Group, LLC.:
Laurence Watts, 619-916-7620 laurence@gilmartinir.com
Media Revance Therapeutics, Inc.: Cathryn Castaldo,
615-245-7567 cathryn.castaldo@revance.com
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From Apr 2024 to May 2024
Revance Therapeutics (NASDAQ:RVNC)
Historical Stock Chart
From May 2023 to May 2024